We found that 77.5% AA tumors harbor at least one of the nine gene signatures associated with ERG-negative tumors indicating similar patterns between prostate cancers of AA patients and the overall genomic alteration pattern of ERG-negative tumors (Fig. 3b). This evidence concerns the gene ERG and prostate cancer.